FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
FDA General

Gottlieb TV Appearance Endorses Overton FDA Nomination

Former FDA head Scott Gottlieb appears on CNBC to throw his support behind commissioner-nominee Heidi Overton on the eve of her Senate confirmation he...

Medical Devices

Multiple Types of Violations at Specialty Health Products

FDA warns Phoenix, AZ-based Specialty Health Products about multiple violations in its marketing of unapproved colonic irrigation systems.

latest-news-card-1
Biologics

CBER Sponsor Regulatory Meetings SOPP

CBER issues a Standard Operating Policy and Procedure on scheduling and conducting regulatory meetings on drugs and biologics.

latest-news-card-1
FDA General

FDA Consent Decree Against Gold Star Distribution

A federal court has entered a consent decree of permanent injunction against Gold Star Distribution, Inc., prohibiting the Minnesota warehouse operato...

latest-news-card-1
Biologics

Are Comparative Clinical Studies of Biologics Worth the Time and Cost?

FDA says a meta-analysis performed by CDER scientists suggests that pharmacokinetic similarity studies can often yield sufficient information on biosi...

latest-news-card-1
Human Drugs

3 Observations in STAQ Pharma Inspection

FDA releases the Form FDA-483 with three observations from its inspection at the Columbus, OH-based STAQ Pharma Ohio outsourcing facility.

latest-news-card-1
Medical Devices

FDA Panel Backs Grail's Galleri Multi-Cancer Blood Test

An FDA advisory committee votes Wednesday to recommend approval of Grail's Galleri multi-cancer early detection blood test, voting unanimously, 10-0, ...

latest-news-card-1
Human Drugs

Improve Substantial Effectiveness Draft Guidance: Stakeholders

Four major stakeholders give numerous suggestions for significantly changing or improving an FDA draft guidance that revises the agencys approach to d...

Human Drugs

Proteomic Biomarker Framework to Speed Drug Development

An FDA online post explains the benefits of CDER scientists work in proteomics-based biomarker discovery.